Tongue

Microbix Unveils Test Controls for Head and Neck Cancer

Retrieved on: 
Lunedì, Marzo 11, 2024
Woman, EQA, Sunnybrook Health Sciences Centre, QAP, TSX, Cancer, Throat, Exhibition, Dartmouth–Hitchcock Medical Center, IHC, Quality control, Mouth, Diagnosis, Tongue, Accreditation, Histology, Palate, Papillomaviridae, HPV, OTCQX, PCR, QC, Laboratory, Research, Nose, Head and neck cancer, Medical imaging

While HPV is best known for causing cancers of the cervix in women, this virus family also causes cancer in other bodily tissues.

Key Points: 
  • While HPV is best known for causing cancers of the cervix in women, this virus family also causes cancer in other bodily tissues.
  • Such further types of HPV-driven cancer include those of the “Head and Neck,” collectively tumours inside and behind the nose, throughout the mouth (including the tongue, gums, and palate), all sections of the throat, and the voice box.
  • Unfortunately, a lack of standardized and reproducible reference samples makes it challenging to control the recommended test workflows for diagnosing such cancers.
  • These standardized and reproducible tissue-oriented test controls will then be added to Microbix’s catalogue of QAPs, expanding its activities into support of oncology workflows alongside its wide range of infectious disease test controls.

ARS Pharmaceuticals Reviews Recent Clinical Updates and Commercial Opportunity at neffy® Investor Day

Retrieved on: 
Giovedì, Marzo 7, 2024
Type 1, Allergy, SAN, Anxiety, EMA, Caregiver, CRL, New Drug Application, ARS, FDA, Food, Larynx, University of South Florida, Anaphylaxis, Vomiting, Entrepreneurship, Symantec Endpoint Protection, Angioedema, University, Event, Tongue, Webcast, Patient, Pediatrics, Adrenaline, Population growth, Prescription, Irritation, Face, Pharmaceutical industry

The event included presentations by members of the ARS Pharma management team and by two distinguished allergists, Dr. Jonathan Spergel, M.D., Ph.D. and Dr. Thomas B. Casale, M.D.

Key Points: 
  • The event included presentations by members of the ARS Pharma management team and by two distinguished allergists, Dr. Jonathan Spergel, M.D., Ph.D. and Dr. Thomas B. Casale, M.D.
  • Of the patients that do fill their prescription, 80-90% either do not carry or use their treatment as indicated.
  • In late-February, the Company announced positive clinical data from a Phase 2 trial evaluating neffy in adults with chronic spontaneous urticaria.
  • The webcast replay and accompanying slides from today’s investor event may be accessed through the Events & Presentations page in the Investors & Media section of the Company's website.

New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PT

Retrieved on: 
Giovedì, Marzo 7, 2024
Ethos, Investment, Game, Somnolence, Veterinarian, Blue Castle, Horse, Fatigue, Patient, Host, CCL, OTCQB, Social media, Privacy, Street, Television presenter, Pain, Dog, VMX, Veterinary medicine, Collectable, OTCQX, Multi, Pet, Woman, VRM, FRA, Sleep, Ligament, Insomnia, COP, Game Changer, Cat, FBI, Fibromyalgia, Osteoarthritis, Recycling, Speech, Waste management, Internet, Tonix Pharmaceuticals, MD, Hacks, FDA, Non-fungible token, Tongue, Headache, Medicine

First, in October 2023, veterinarians presented SPRYNG™'s positive study results on dogs with cranial cruciate ligament (CCL) disease.

Key Points: 
  • First, in October 2023, veterinarians presented SPRYNG™'s positive study results on dogs with cranial cruciate ligament (CCL) disease.
  • Also, Ethos Veterinary Health, LLC's study on canine hip dysplasia using the product shows success, giving more veterinary doctors information about product uses.
  • PETV's SPRYNG™ with OsteoCushion Technology is a "Game Changer" medical device that successfully treats pets and gives owners options beyond surgeries.
  • New to The Street airs TV Host Jane King's interview with VRM BioLogik® Group's (VRM) Ken Bellamy, Founder and President .

Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in China

Retrieved on: 
Lunedì, Febbraio 26, 2024
FDA, Health, Neurology, Clinical Trials, Pharmaceutical, Biotechnology, Tardive dyskinesia, Chorea, VMAT2, Metabolism, EVP, Deuterium, Annual report, TEVA, Marketing, Teva, Partnership, HD, Quality of life, Food, Schizophrenia, Neurological disorder, DSM-IV codes, Globalization, Neuro, Prevalence, Happy Mood, Face, Anesthesia, Central nervous system disease, Pivot, Tongue, CNS, Psychiatry, Patient, Pain, Disease, Extremities, Research, Pharmaceutical industry

The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.

Key Points: 
  • The partnership intends to increase patients’ access to Teva’s AUSTEDO, leveraging Nhwa’s leadership in China’s neuro-psychiatric health sector.
  • “Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee, General Manager of Teva Greater China.
  • Chorea, one of the most striking physical manifestations of Huntington’s disease, is a neurological disorder that causes involuntary, random muscle movements.
  • Jiangsu Nhwa Pharmaceutical Co., Ltd., founded in 1978, is a leading CNS company in China.

LP Building Solutions Launches Innovative LP® SmartSide® Nickel Gap Siding

Retrieved on: 
Giovedì, Febbraio 22, 2024
Commercial Building & Real Estate, Construction & Property, Natural Resources, Building Systems, Other Natural Resources, Other Construction & Property, Forest Products, Residential Building & Real Estate, LP, Tongue, Multimedia, Nickel, Beauty, Cassette tape

LP Building Solutions (LP), a leading manufacturer of high-performance building products, is proud to announce the launch of its newest siding solution, LP® SmartSide® Nickel Gap Siding, available nationwide beginning March 1, 2024.

Key Points: 
  • LP Building Solutions (LP), a leading manufacturer of high-performance building products, is proud to announce the launch of its newest siding solution, LP® SmartSide® Nickel Gap Siding, available nationwide beginning March 1, 2024.
  • View the full release here: https://www.businesswire.com/news/home/20240222686447/en/
    LP® SmartSide® Nickel Gap Siding (Photo: Business Wire)
    Nickel Gap Siding will be available in a brushed smooth and cedar texture in 16 prefinished LP® SmartSide® ExpertFinish® colors and in a primed LP® SmartSide® cedar texture.
  • LP® SmartSide® Nickel Gap Siding is backed by an industry-leading 5/50-year limited warranty, and LP® SmartSide® ExpertFinish® Nickel Gap Siding includes a 15-year limited warranty on the finish, helping to ensure durability and peace of mind for builders and homeowners.
  • With the introduction of Nickel Gap Siding, LP continues to be at the forefront of innovation, offering builders and homeowners an opportunity to provide modern and reliable siding solutions.

Sleep Center of Littleton Introduces an Alternative to CPAP Therapy

Retrieved on: 
Mercoledì, Febbraio 28, 2024
CPAP, Sleep apnea, Sleep, Patient, Hope, Tongue, Mask, Travel, Jaw, Pharmaceutical industry

LITTLETON, Colo., Feb. 28, 2024 /PRNewswire/ -- Sleep Center of Littleton, a leading provider of sleep apnea treatment, is excited to announce the introduction of an innovative alternative to Continuous Positive Airway Pressure (CPAP) therapy.

Key Points: 
  • LITTLETON, Colo., Feb. 28, 2024 /PRNewswire/ -- Sleep Center of Littleton, a leading provider of sleep apnea treatment, is excited to announce the introduction of an innovative alternative to Continuous Positive Airway Pressure (CPAP) therapy.
  • Recognizing these challenges, Sleep Center of Littleton is now offering an excellent alternative: oral appliance therapy.
  • "The introduction of oral appliance therapy is a game-changer for individuals who have struggled with CPAP therapy," said Dr. Thomas R. Froning, a Qualified Sleep Dentist and founder of Sleep Center of Littleton.
  • For individuals who have struggled with CPAP therapy or are searching for an effective alternative, Sleep Center of Littleton offers a ray of hope.

HTC VIVE launches new enterprise-focused VIVE XR Elite Business Edition package

Retrieved on: 
Lunedì, Febbraio 26, 2024
Personal, Financial services, HTC, AI, MWC, ACCESS, Chin, Arcade, Location, Enterprise, Tongue, SDK, Organization, Impressionism, XR, VR, International Space Station, Museum, Speech, VIVE, Jaw, Video game

At MWC 2024, HTC VIVE is announcing new enterprise features for VIVE XR Elite Business Edition , including Location Based Software Suite support, and VIVE Business+ to make fleet management and content deployment effortless at any scale.

Key Points: 
  • At MWC 2024, HTC VIVE is announcing new enterprise features for VIVE XR Elite Business Edition , including Location Based Software Suite support, and VIVE Business+ to make fleet management and content deployment effortless at any scale.
  • VIVE XR Elite Business Edition also has new physical accessories to support even more versatile use cases, and enhance comfort for longer sessions or multiple users.
  • "Every year, the XR industry is delivering more innovation to support humanity," said Cher Wang, Chairwoman and Co-Founder of HTC.
  • The VIVERSE Starter Pack promotion includes:
    10x free VIVE XR Elite Business Edition units, including free VIVE Business Warranty
    20x VIVE XR Elite Business Edition bundle also available, with total savings over $15,000
    VIVERSE is also adding a number of new features, including AI tools, support for VIVE Ultimate Tracker and VIVE Full Face Tracker for VIVE XR Elite, as well as non-VR motion capture for avatars.

Saucony® x Bodega Launch Limited - Edition Sneaker Collab

Retrieved on: 
Venerdì, Febbraio 23, 2024
Collection, Red Alert, Marketing, Woman, Friends, Grain, Grid, Nature, EVA, Tongue, Creativity, Heel, Pressure, Partnership

ROCKFORD, Mich. , Feb. 23, 2024 /PRNewswire/ -- Saucony, leading global performance running lifestyle brand, today announced its first collaboration of the year with longtime partner and renowned curator of fashion and streetwear Bodega. The limited-edition Bodega x Saucony Grid Shadow 2 'Jaunt Woven' will be available online at Bodega today Friday, Feb. 23 and Saucony.com beginning March 1.

Key Points: 
  • The limited-edition Bodega x Saucony Grid Shadow 2 'Jaunt Woven' will be available online at Bodega today Friday, Feb. 23 and Saucony.com beginning March 1.
  • The Bodega x Saucony Grid Shadow 2 'Jaunt Woven' combines stone washed 18oz canvas, hemp and cotton with rope laces to lock down the design ethos inspired by aimless adventure.
  • Primarily made from woven hemp and featuring natural hues, the sneaker owes its definition to the contrasting weaves.
  • The release marks another milestone in the long lineage of successful collaborations between Saucony and Bodega.

P448'S REGENERATIVE SUSTAINABLITY® PROGRAM CONTINUES ITS EDUCATIONAL SPOTLIGHT ON INVASIVE SPECIES WITH THE LAUNCH OF ITS BURMESE PYTHON SNEAKER

Retrieved on: 
Martedì, Febbraio 20, 2024
Predation, Capsule, Bird, GRS, Education, Biodiversity, Skin, UPC, Food, Wilderness, Tongue, London Fashion Film Festival, Ecosystem, Mammal, QR, Shoe, Everglades National Park, Research, Environment, Tourism

NEW YORK, Feb. 20, 2024 /PRNewswire/ -- Carving its path as an innovative fashion company with creative sustainability solutions, P448 continues its eco-friendly message of trying to help solve an environmental crisis while protecting the biodiversity with its "Regenerative Sustainability®" program. For the resort season, the brand launches its Burmese python sneaker. This is the 3rd dedicated capsule to educate, spotlight and bring awareness to the vast issues posed by invasive species to our environment – previous P448 invasive species sneaker capsules included the lionfish and carp fish.

Key Points: 
  • This is the 3rd dedicated capsule to educate, spotlight and bring awareness to the vast issues posed by invasive species to our environment – previous P448 invasive species sneaker capsules included the lionfish and carp fish.
  • Burmese pythons disrupt the ecosystem by preying on native species, outcompeting native species for food or other resources and/or disrupt the physical nature of the environment.
  • The Burmese python sneaker trim is boldly detailed with repurposed natural black and white python skin from the invasive species within the front tip, tongue and heel areas of its strikingly chic silhouette.
  • The Burmese python sneaker is available at www.p448.com and select global wholesale partners with a suggested retail price of $595.

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

Retrieved on: 
Venerdì, Febbraio 16, 2024
Carbon, Hospital, Watt, Mining, News, Somnolence, DNX, Bacteria, FINRA, Global X ETFs, Patient, Corporation, BTC, POW, Biopharmaceutical, Television, Carbon footprint, Pain, Wind, CDI, Vancomycin, Fox Business, Ecosystem, SBP, Interview, Miner, Partnership, Woman, Nursing, Sleep, ESG, Insomnia, Business, Decentralization, EnergySolutions, Fibromyalgia, Tonix Pharmaceuticals, MD, Sustainability, FDA, Patent, SBC, Food, Tongue, United States patent law, Medicine, Headache, Publication, Cryptocurrency

New to The Street's Episode 556 line-up features the following five (5) Corporate interviews:

Key Points: 
  • New to The Street's Episode 556 line-up features the following five (5) Corporate interviews:
    2).
  • Tonix's new drug, called Tonmya™, is a new class of medicine that controls pain in those who have fibromyalgia.
  • Fibromyalgia is common in women who have been unsuccessful in finding current marketplace drugs limited in the treatment success.
  • Clinical studies have shown that Tonmya™ can eliminate most pain, enhance sleep, and diminish fatigue in patients.